142 related articles for article (PubMed ID: 25468034)
1. Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors.
Lee YH; Shin MC; Yun YD; Shin SY; Kim JM; Seo JM; Kim NJ; Ryu JH; Lee YS
Bioorg Med Chem; 2015 Jan; 23(1):231-40. PubMed ID: 25468034
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.
Nam SO; Park DH; Lee YH; Ryu JH; Lee YS
Bioorg Med Chem; 2014 Feb; 22(4):1262-7. PubMed ID: 24485122
[TBL] [Abstract][Full Text] [Related]
3. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives.
Sheng R; Xu Y; Hu C; Zhang J; Lin X; Li J; Yang B; He Q; Hu Y
Eur J Med Chem; 2009 Jan; 44(1):7-17. PubMed ID: 18436348
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.
Mehrabi F; Pourshojaei Y; Moradi A; Sharifzadeh M; Khosravani L; Sabourian R; Rahmani-Nezhad S; Mohammadi-Khanaposhtani M; Mahdavi M; Asadipour A; Rahimi HR; Moghimi S; Foroumadi A
Future Med Chem; 2017 May; 9(7):659-671. PubMed ID: 28485614
[TBL] [Abstract][Full Text] [Related]
7. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
Delogu GL; Matos MJ; Fanti M; Era B; Medda R; Pieroni E; Fais A; Kumar A; Pintus F
Bioorg Med Chem Lett; 2016 May; 26(9):2308-13. PubMed ID: 26995529
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of benzofuran derivatives via rearrangement and their inhibitory activity on acetylcholinesterase.
Zhou X; Li M; Wang XB; Wang T; Kong LY
Molecules; 2010 Nov; 15(12):8593-601. PubMed ID: 21116228
[TBL] [Abstract][Full Text] [Related]
9. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Semenov VE; Zueva IV; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
ChemMedChem; 2015 Nov; 10(11):1863-74. PubMed ID: 26412714
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
Anand P; Singh B
Bioorg Med Chem; 2012 Jan; 20(1):521-30. PubMed ID: 22172310
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
[TBL] [Abstract][Full Text] [Related]
12. 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.
Rizzo S; Tarozzi A; Bartolini M; Da Costa G; Bisi A; Gobbi S; Belluti F; Ligresti A; Allarà M; Monti JP; Andrisano V; Di Marzo V; Hrelia P; Rampa A
Eur J Med Chem; 2012 Dec; 58():519-32. PubMed ID: 23164658
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
Szymański P; Janik A; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
15. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.
Rizzo S; Rivière C; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Morroni F; Tarozzi A; Monti JP; Rampa A
J Med Chem; 2008 May; 51(10):2883-6. PubMed ID: 18419109
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease.
Xu ZC; Wang XB; Yu WY; Xie SS; Li SY; Kong LY
Bioorg Med Chem Lett; 2014 May; 24(10):2368-73. PubMed ID: 24726809
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.
Basiri A; Xiao M; McCarthy A; Dutta D; Byrareddy SN; Conda-Sheridan M
Bioorg Med Chem Lett; 2017 Jan; 27(2):228-231. PubMed ID: 27914796
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
Mostofi M; Mohammadi Ziarani G; Mahdavi M; Moradi A; Nadri H; Emami S; Alinezhad H; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 Oct; 103():361-9. PubMed ID: 26363872
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
Singh M; Kaur M; Kukreja H; Chugh R; Silakari O; Singh D
Eur J Med Chem; 2013; 70():165-88. PubMed ID: 24148993
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
Zurek E; Szymański P; Mikiciuk-Olasik E
Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
